Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), a global leader in medical cannabis throughout Europe and Latin America, today announced that Alvaro Torres, CEO and Director of the Company will be attending the Q3 Virtual Investor Summit. Event: Q3 Investor Summit Date: August 16 & 17th, 2022 Presentation: August 17 @ 9:30am ET Location:... Read More